We compared allele frequencies of MITF (E318K) for the familial (MAF = 0.6%) and sporadic (MAF = 0.6%) melanoma cohorts and did not observe any difference, suggesting that the sporadic cohort should be powerful enough to detect primary cancer risks associated with MITF(E318K). The gene discussed is MITF; the disease is melanoma.